These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


972 related items for PubMed ID: 18402842

  • 1. Cardiomyocyte death and renewal in the normal and diseased heart.
    Buja LM, Vela D.
    Cardiovasc Pathol; 2008; 17(6):349-74. PubMed ID: 18402842
    [Abstract] [Full Text] [Related]

  • 2. Cardiac c-kit+AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance.
    Altarche-Xifró W, Curato C, Kaschina E, Grzesiak A, Slavic S, Dong J, Kappert K, Steckelings M, Imboden H, Unger T, Li J.
    Stem Cells; 2009 Oct; 27(10):2488-97. PubMed ID: 19591228
    [Abstract] [Full Text] [Related]

  • 3. Can the cardiomyocyte cell cycle be reprogrammed?
    Bicknell KA, Coxon CH, Brooks G.
    J Mol Cell Cardiol; 2007 Apr; 42(4):706-21. PubMed ID: 17362983
    [Abstract] [Full Text] [Related]

  • 4. The role of autophagy in the heart.
    Nishida K, Kyoi S, Yamaguchi O, Sadoshima J, Otsu K.
    Cell Death Differ; 2009 Jan; 16(1):31-8. PubMed ID: 19008922
    [Abstract] [Full Text] [Related]

  • 5. Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration.
    Torella D, Ellison GM, Méndez-Ferrer S, Ibanez B, Nadal-Ginard B.
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S8-13. PubMed ID: 16501638
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of Fas in the progression of ischemic heart failure: prohypertrophy or proapoptosis.
    Feng QZ, Zhao YS, Abdelwahid E.
    Coron Artery Dis; 2008 Nov; 19(7):527-34. PubMed ID: 18923250
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Early origins of cardiac hypertrophy: does cardiomyocyte attrition programme for pathological 'catch-up' growth of the heart?
    Porrello ER, Widdop RE, Delbridge LM.
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1358-64. PubMed ID: 18759854
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Studying ischemic preconditioning in isolated cardiomyocyte models.
    Diaz RJ, Wilson GJ.
    Cardiovasc Res; 2006 May 01; 70(2):286-96. PubMed ID: 16413515
    [Abstract] [Full Text] [Related]

  • 13. Detection of TUNEL-positive cardiomyocytes and c-kit-positive progenitor cells in children with congenital heart disease.
    Sato H, Shiraishi I, Takamatsu T, Hamaoka K.
    J Mol Cell Cardiol; 2007 Sep 01; 43(3):254-61. PubMed ID: 17631310
    [Abstract] [Full Text] [Related]

  • 14. Neovascularization and cardiac repair by bone marrow-derived stem cells.
    Badorff C, Dimmeler S.
    Handb Exp Pharmacol; 2006 Sep 01; (174):283-98. PubMed ID: 16370332
    [Abstract] [Full Text] [Related]

  • 15. Role of apoptosis in remodeling after myocardial infarction.
    Takemura G, Fujiwara H.
    Pharmacol Ther; 2004 Oct 01; 104(1):1-16. PubMed ID: 15500905
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart.
    Wohlschlaeger J, Levkau B, Brockhoff G, Schmitz KJ, von Winterfeld M, Takeda A, Takeda N, Stypmann J, Vahlhaus C, Schmid C, Pomjanski N, Böcking A, Baba HA.
    Circulation; 2010 Mar 02; 121(8):989-96. PubMed ID: 20159834
    [Abstract] [Full Text] [Related]

  • 17. New directions in strategies using cell therapy for heart disease.
    Itescu S, Schuster MD, Kocher AA.
    J Mol Med (Berl); 2003 May 02; 81(5):288-96. PubMed ID: 12698252
    [Abstract] [Full Text] [Related]

  • 18. Myocyte death and renewal: modern concepts of cardiac cellular homeostasis.
    Ellison GM, Torella D, Karakikes I, Nadal-Ginard B.
    Nat Clin Pract Cardiovasc Med; 2007 Feb 02; 4 Suppl 1():S52-9. PubMed ID: 17230216
    [Abstract] [Full Text] [Related]

  • 19. Cardiomyocytes derived from stem cells.
    Van Laake LW, Van Hoof D, Mummery CL.
    Ann Med; 2005 Feb 02; 37(7):499-512. PubMed ID: 16278163
    [Abstract] [Full Text] [Related]

  • 20. How hematopoietic stem cells know and act in cardiac microenvironment for stem cell plasticity? Impact of local renin-angiotensin systems.
    Oztürk MA, Güven GS, Haznedaroglu IC.
    Med Hypotheses; 2004 Feb 02; 63(5):866-74. PubMed ID: 15488662
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 49.